25611228Spigel DR, Patel JD, Reynolds CH, Garon EB, Hermann RC, Govindan R, Olsen MR, Winfree KB, Chen J, Liu J, Guba SC, Socinski MA, Bonomi PJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerAntineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Lung NeoplasmsAntibodies, Monoclonal, Humanized; Bevacizumab; Carboplatin; Drug Administration Schedule; Female; Glutamates; Guanine; Humans; Male; Neoplasm Staging; Paclitaxel; Pemetrexed; Quality of Life; Treatment OutcomeQuality of life analyses from the randomized, open-label, phase III PointBreak study of pemetrexed-carboplatin-bevacizumab followed by maintenance pemetrexed-bevacizumab versus paclitaxel-carboplatin-bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer. J Thorac Oncol. 2015 Feb; 10(2):353-9.J Thorac Oncol2015-02-01T00:00:002015Quality of life analyses from the randomized, open-label, phase III PointBreak study of pemetrexed-carboplatin-bevacizumab followed by maintenance pemetrexed-bevacizumab versus paclitaxel-carboplatin-bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.Faculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD005971Chemicals & Drugs7170.991318GlutamatesD016896Concepts & Ideas36434750.519213Treatment OutcomeD006147Chemicals & Drugs5110.996933GuanineD009367Concepts & IdeasProcedures713400.910359Neoplasm StagingPhilipBonomiPhilip Bonomi349183Bonomi, PhilipProfessorD016190Chemicals & Drugs17490.983623CarboplatinAuthorship 4224134ProfessorD061067Chemicals & Drugs411130.922308Antibodies, Monoclonal, Humanized0.5302470.5302471authors10.2517has subject areaD017239Chemicals & Drugs22740.972772PaclitaxelD008297Physiology564156270.299065MaleD011788Concepts & Ideas1826600.687631Quality of LifeD005260Physiology579162020.293532FemaleRush University, Rush Medical CollegeD002289Disorders253160.769548Carcinoma, Non-Small-Cell LungD000971Procedures542900.853586Antineoplastic Combined Chemotherapy ProtocolsD004334Concepts & Ideas842230.947666Drug Administration ScheduleInternal Medicine, Division of Hematology/Oncology/Cell Therapytrue1ProfessorProfessorD008175Disorders646250.65394Lung NeoplasmsD006801Living Beings643293340.211949HumansD0000682588270.990946BevacizumabD0000684374140.993958Pemetrexed